Related references
Note: Only part of the references are listed.Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
Nadia Stefanova et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
M. Cote et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Toll-like receptors
Eva Marie Y. Moresco et al.
CURRENT BIOLOGY (2011)
Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease
Candan Depboylu et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
Janelle Drouin-Ouellet et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Dawn Béraud et al.
PARKINSONISM & RELATED DISORDERS (2011)
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
Francisco Ros-Bernal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
alpha-Synuclein alters toll-like receptor expression
Dawn Beraud et al.
FRONTIERS IN NEUROSCIENCE (2011)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Quantitative Trait Loci Associated with Susceptibility to Bladder and Kidney Infections Induced by Escherichia coli in Female C3H/HeJ Mice
Walter J. Hopkins et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Expression of TLR4 and CD14 in the Central Nervous System (CNS) in a MPTP Mouse Model of Parkinson's-Like Disease
Maria Antonietta Panaro et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2008)
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
Daniel Alvarez-Fischer et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system
D. Skrzydelski et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females
JJ Lin et al.
PARKINSONISM & RELATED DISORDERS (2006)
Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components
N Laflamme et al.
FASEB JOURNAL (2001)